Baclofen in the Treatment of Alcoholic Liver Disease

1 in 10 Australian adults consume alcohol at levels that are risky for liver disease. Alcoholic liver disease is both the leading cause of alcohol-related death in Australia.

Abstinence from alcohol is crucial to reducing morbidity and mortality associated with the disease. However, specific treatments for alcohol use disorders in those with significant liver disease have been lacking.

There is recent clinical evidence to indicate that the medication, baclofen, which is safe on the liver, has therapeutic value in alcohol dependence.

We are currently offering a 12 week treatment program for people with alcoholic liver disease. This includes:
Medical assessments by our specialists (fibroscan) plus monitoring of liver function symptoms

  • 12 weeks of free medication
  • Up to 8 brief counselling sessions

Would the program suit me?

  • Is it becoming difficult to cut down or control your drinking?
  • Have you been drinking regularly (>4 drinks per day) for at least 10 years?
  • Do you suffer from (or suspect you may have) liver disease?
  • Are you willing to participate in a randomised controlled trial?

Does this sound like you? The best way to find out whether you are likely to benefit from our program is to complete a short phone interview with one of our experienced staff. We are happy to answer any questions you have about our program.

Please contact one of the team members on (02) 9515 3636 or for more information about this trial.

Patients seeking help for their alcohol problems must be aged between 18 and 75 years, and must be willing to attend regular medical and brief counselling/research appointments for a period of 12 weeks.
Participation in all trials is completely free of charge and you will be reimbursed for you time and travel at the final follow-up appointments.

Click here for Frequently Asked Questions about the medication baclofen.